Quinacrine Dihydrochloride — Class I drug recall D-0125-2020
Terminated recall by Darmerica, LLC, reported 2019-10-02, distributed nationwide. Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin
| Recall number | D-0125-2020 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Darmerica, LLC, Casselberry, FL, United States |
| Recall initiated | 2019-09-06 |
| Classified | 2019-10-03 |
| Reported by FDA | 2019-10-02 |
| Terminated | 2021-02-05 |
| Distributed | Nationwide (US) |
| Quantity | 1.8 kilograms |
| Reason classes | labeling |
| NDC | 71052-0530-05, 71052-0530-25, 71052-0530-55 |
| Expiration dates | 2021-04-27 |
Product
Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-55, c) 25g NDC# 71052-530-25, Darmerica LLC 198 Wilshire Blvd Casselberry, FL 32707
Reason for recall
Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0125-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.